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Available online 26 September 2012Abstract Neural stem cells (NSCs) raised the hope for cell-based therapies in human neurodevelopmental and
neurodegenerative diseases. Current research strategies aim to isolate, enrich, and propagate homogeneous populations of
neural stem cells. Unfortunately, several concerns with NSC cultures currently may limit their therapeutic promise. Exhaustion
of growth factors and/or their uncontrolled release with burst and fall in their concentration may greatly affect the in vitro
behavior of NSCs. In this context, we investigate whether a device containing heparan sulfate (HS), which is a co-factor in
growth factor-mediated cell proliferation and differentiation, could potentiate and prolong the delivery of fibroblast growth
factor-2 (FGF-2) and thus improve in vitro NSC cultivation. We demonstrated that NSCs cultivated in media with a controlled
release of FGF-2 from a polyelectrolyte polymer showed a higher proliferation rate, and reduced apoptosis and senescence. In
these experimental conditions NSCs preserve their stemness properties for a longer period of time compared with controls. Also
of interest is that cell fate properties are conserved as well. The controlled release of FGF-2 reduced the level of oxidative
stress and this is associated with a lower level of damaged DNA. This result may explain the reduced level of senescence and
apoptosis in NSCs cultivated in the presence of hydrogel-releasing FGF-2.
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Neural stem cells (NSCs) are referred to as self-renewing cells
derived from the nervous system that can give rise to cells
other than themselves through asymmetric division (Gage,
2000). NSCs have been found not only in the embryonic brain
86 U. Galderisi et al.but also in the adult nervous system of all mammalian
organisms. These cells are able to proliferate and differentiate
into the threemajor cell types of the nervous system (neurons,
astrocytes, and oligodendrocytes) both in vivo and in vitro
(Gritti et al., 1995; Jori et al., 2007; Reynolds andWeiss, 1992;
Vescovi et al., 1993).
NSCs hold tremendous promise for fundamental biological
studies and cell-based therapies in human neurodevelopmental
and neurodegenerative diseases, such as Alzheimer's and
Parkinson's diseases, for which effective therapies are limited
or lacking. Unfortunately, several concerns with NSC cultures
currently may limit their therapeutic promise. One major
problem is the inability to precisely control stem cell behavior
in culture, such as proliferation and specification into different
cell types.
NSCs are cultivated in serum-free media supplemented
with several hormones and cytokines (Gritti et al., 1995; Jori
et al., 2007; Reynolds andWeiss, 1992; Vescovi et al., 1993). It
has been established that the adult mouse forebrain contains
NSCs that can be cultivated in vitrowhen EGF or FGF-2 or their
combination is provided (Gritti et al., 1995). In particular,
FGF-2 was shown to promote the growth rate of NSCs in vitro
thereby maintaining their multilineage differentiation poten-
tial (Gritti et al., 1995). However, FGF-2's susceptibility to
enzymatic degradation may limit its clinical applications.
Several methods have been used to produce a controlled
release of FGF-2 both in vivo and in vitro, namely, encapsu-
lation of heparin-Sepharose bound FGF-2 in alginate beads,
impregnation of collagen sponges with heparin-FGF-fibrin
mixtures, and FGF-2 incorporation into hyaluronate gels or
gelatin hydrogels (DeBlois et al., 1994; Edelman et al., 1991;
Tabata et al., 1998; Yamada et al., 1997). However, these
delivery systems resulted in complete FGF-2 release either in
an initial burst or within 3 days. Differently, the release of FGF
lasted weeks or months in poly(d,l-lactide-coglycolide) and
acidic gelatin delivery systems, or in heparin conjugated
micelle or in other carriers, but it is not known whether these
systems can be toxic for in vitro cultivation of stem cells (Hile
et al., 2000; Ikada and Tabata, 1998; Lee et al., 2008).
Furthermore, FGF-2, like other bioactive factors used for
regenerative medical applications, usually works in a synchro-
nized manner with other growth factors or co-factors during
the cell differentiation process (Chen and Mooney, 2003).
Indeed, FGF-2 has an important characteristic: its activity is
positively regulated by the addition of exogenous heparan
sulfate (HS) (Turnbull et al., 2001). Thanks to their variably
sulfated domain structure, HS polysaccharides form charged
binding pockets. This process enablesmany different modes of
binding with an individual protein thus endowing the protein
with regulatory properties (Bernfield et al., 1999). The
binding of FGF-2 toHS protects it fromproteolytic degradation
and prolongs its half-life. HS also functions as a modulator of
FGF-2 activity, not as an anionic binder that stabilizes the
receptor complex, but as a specific initiator of FGF signaling
(Friedl et al., 1997). In our previous work we demonstrate that
a device containing HS, which could potentiate and prolong
the delivery of FGF-2, is not toxic for in vitro cultivation of
various cell types and may even improve their in vitro
cultivation (Calarco et al., 2010; De Rosa et al., 2004). On
this premise, we decided to evaluate this experimental
platform for optimizing NSC proliferation and differentiation
conditions.Materials and methods
Materials
2-Hydroxyethyl methacrylate (HEMA), 2-methacryloyloxy-
ethyltrimethyl ammonium chloride (METAC) and all chemical
reagents were obtained from Sigma-Aldrich, (Milan, Italy).
Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum
(FBS), penicillin–streptomycin, trypsin, and Dulbecco's phos-
phate buffered saline (PBS) were purchased from Hyclone
(Milan, Italy). Plastic tissue cultures were from Falcon (Milan,
Italy). Surfen (bis-2-methyl-4-amino-quinolyl-6-carbamide) was
synthesized and stored in glass containers at −20 °C in the
absence of light. Fresh aqueous solutions were prepared from
30 mM stock solutions in dimethyl sulfoxide as needed. Heparan
sulfate (HS), and heparinases (I, II, and III) were obtained from
Sigma-Aldrich, while human recombinant fibroblast growth
factor-2 (FGF-2) was obtained from R&D Systems (Milan, Italy).
Stock solutions of 2 mg/ml HS, and 25 mg/ml FGF-2 were
prepared.
Scaffold synthesis and FGF-2 release
Polyelectrolyte-modified HEMA hydrogel p[HEMA-co-METAC]
(pHM) was obtained by copolymerization of HEMA with the
cationic monomer METAC at a ratio of 10:1 mol/mol as
previously described (De Rosa et al., 2004; Denizli and Piskin,
1995). The loaded hydrogels were prepared as follows: in the
case of pHM dried polymer discs were incubated with an FGF-2
solution, or a heparan sulfate (HS) solution before the addition
of FGF-2. The ratios of HS to FGF-2 were 0.5:25 mg/mg. The
pHM/HS hydrogel was incubated with FGF-2 (25 μg). To study
the kinetics of FGF-2 release, loaded hydrogels were allowed to
swell in 2 ml of PBS for 14 days at 37 °C in a humidified
atmosphere. Supernatants were removed at different times
and stored at −20 °C before assay. The amount of FGF-2 in
each sample was determined in triplicate by ELISA. In the
presence of HS/FGF-2 complexes, the solution was treated
with heparinases before assay. Absorbance was measured at
450 nm on a microplate reader (see also supplemental file 1).
Animal and NSC cultures
Neural stem cells were obtained from the subventricular
zone (SVZ) of the brain of adult mice. A thin tissue layer
surrounding the ventricles was isolated from coronal slices
of the brain of sacrificed animals. After two washes in PBS, the
tissue was treated with a dissociation solution, composed of
bovine hyaluronidase, type IV-S 660 μg/ml (Sigma-Aldrich
Italia, Milano, Italy), DNAse I 40 μg/ml (Sigma-Aldrich Italia),
kinurenic acid 0.2 mg/ml (Sigma-Aldrich Italia), trypsin 0.125%
(Invitrogen Italia, Milano, Italy) in PBS, for 5 min at 37 °C and
triturated with a Pasteur pipette. Then, twenty volumes of
DMEM/F12 (1:1) (Invitrogen Italia) were added and the tissues
were centrifuged. The pellet was resuspended in DMEM/F12
(1:1) and passed through a 125 μm nylon mesh (BD Biosciences
Italia, Milano, Italy). Finally, the cellular suspension was
centrifuged again and resuspended in “classical culture medi-
um”, composed of DMEM/F12 (1:1), 1× B27, 2.5 μg/ml
Fungizone, 100 U/ml penicillin, 100 μg/ml streptomycin (all
from Invitrogen Italia) and 20 ng/ml EGF and 20 ng/ml
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5–6 days floating neurospheres were evident in the culture.
They were pelleted and treated with the dissociation
solution to obtain a single cell suspension. Then, cells
were plated again in bacteriological dishes at a concentra-
tion of 2×105/ml in fresh culture medium. Experiments
were performed after 10–12 days of cell amplification in
the culture. In the control cultures the FGF-2 was added
every two days in the medium as above described while in
the treated samples the source of FGF-2 was the loaded
pHM/HS/FGF-2 polymers. Also in this condition we changed
the medium every two days to avoid the accumulation of
waste material and cellular debris. Cultures of cells in
presence of polymers were carried out as described above
with the addition of sterile discs of pHEMA-co-METAC
polymers to culture dishes.NSC differentiation
To induce differentiation, NSCs were plated in DMEM/F12 (1:1),
1× B27, 2.5 μg/ml Fungizone, 100 U/ml penicillin, 100 μg/ml
streptomycin (all from Invitrogen Italia) without FGF-2 at a
density of 5×105 cells/ml onto poly-L-ornithine (Sigma-Aldrich
Italia) coated cell culture plates. Cells were incubated for
3–5 days before immunofluorescence analysis (see below).Cell proliferation and BrdU incorporation
Cell proliferation was evaluated by Quick Cell Proliferation
Assay kit II (Biovision, CA, USA). Following silencing, 1000 cells
were seeded in 96-well culture plates. At 1, 2, 6, 7, 13, 14, 27,
28 days post-plating, cells were collected and counted. The
ratio of the total number of cells at day “n” to the number of
cells at day “n-1” was regarded as the cell proliferation rate
(Nakamura et al., 2008).
BrdU incorporation was evaluated with Cell proliferation
ELISA BrdU colorimetric kit (Roche, Milano, Italy) according
to the manufacturer's instructions.Detection of apoptotic cells
Apoptotic cells were detected by taking advantage of
Fluorescein-conjugated Annexin V (Roche, Italy) following the
manufacturer's instructions. Apoptotic cells were observed
through a fluorescencemicroscope (Leica Italia, Italy). In every
experiment, at least 1000 cells were counted in different fields
to calculate the percentage of dead cells in a culture.Figure 1 FGF-2 release kinetic. The graphic shows the FGF-2
release from the pHM/FGF-2 and pHM/HS/FGF-2. The values
represent the mean±standard deviation. Experiments were
repeated three times. Supernatants were removed at different
times and the amount of FGF-2 in each sample was determined
in triplicate by ELISA. At day 2, 4, 6, 8, 10, 12 the amount of
FGF-2 was determined before medium change.Quantitative senescence-associated
beta-galactosidase assay
A substrate of beta-galactosidase, 4-methylumbelliferyl-
β-D-galactopyranoside (4-MUG) does not fluoresce until
cleaved by the enzyme to generate the fluorophore
4-methylumbelliferone. Assay was carried out on lysates
obtained from cells that were grown in 96 well plates as
reported (Gary and Kindell, 2005). The production of the
fluorophore was monitored at an emission/excitation wave-
length of 365/460 nm.TRAP assay
TRAP assay was carried out according to Kim and co-workers
(Kim and Wu, 1997). In the TRAP PCR reactions the primers
ACX and M2(TS) amplified the telomerase products, while
the primers M2(TS) and NT amplified the TRAP internal
control. PCR products were resolved on polyacrylamide gels
stained with Gelstar (Cambrex Bioscience, Denmark).NSC differentiation and immunofluorescence analysis
We determined the cell type of NSCs by performing
immonofluorescence double stainings on cells grown on
glass coverslips. Three days after the induction of differenti-
ation, cells were fixed with 4% paraformaldehyde for 15 min
followed by three washes in PBS. Slides were then treated with
0.3% Triton X-100 in PBS for 15 min, washed three times in PBS
and incubated for 30 min in a blocking solution containing 5%
nonfat dry milk in PBS. At this point, cells were incubated with
two primary antibodies at the same time. Antibodies were used
for 90 min at room temperature at the following dilutions in 1%
nonfat dry milk in PBS: monoclonal anti-Map2 (Sigma-Aldrich
Italia) 1:20, polyclonal anti-GFAP (Sigma-Aldrich Italia) 1:1000
and monoclonal anti-Rip (DSHB, Iowa City, IA) 1:500. After-
wards, slides were washed three times with PBS and incubated
for 45 min at room temperature with two secondary antibodies
simultaneously (FITC-conjugated anti-mouse Ig and TRITC-
conjugated anti-rabbit Ig, both from Jackson Immunoresearch,
West Grove, PA), diluted 1:100 in 5% nonfat dry milk in PBS.
Finally, after further washes in PBS, glass coverslips were
counterstained with Hoechst 33342 (Sigma-Aldrich Italia)
100 μg/ml for 5 min, washed with water, mounted on glass
slides with Mowiol (Calbiochem, San Diego, CA) containing 2.5%
DABCO (Sigma-Aldrich Italia) and observed through a fluores-
cence microscope (Leica Mycrosystems Italia, Milano, Italy). In
every experiment, at least 2000 cells were counted in 15–20
different fields to calculate the percentage of neurons,
astrocytes, and oligodendrocytes in culture.
88 U. Galderisi et al.
89Efficient cultivation of neural stem cells with controlled delivery of FGF-2Detection of reactive oxygen species (ROS)
The generation of ROS in NSCs wasmonitored by the conversion
of fluorogenic 2′,7′-dichlorodihydrofluorescein diacetate
(DCFH-DA) to highly fluorescent dichlorofluorescein diacetate
(DCF) within cells by ROS. In brief, NSC cultures were
incubated for 1 h at 37 °C with 20 μM DCFH-DA in PBS. Cells
were washed with PBS and then incubated for 30 min with
300 μM for 1 h. Cells were then lysed in a buffer containing
0.1% Triton X-100 for 10 min. Fluorescencewasmeasuredwith
a fluorometric plate reader at 480 nm/530 nm.
8-Oxoguanine detection
8oxodGwithin DNAwas detectedwith OxoguanineGlycosylase
1 (OGG1) ELISA Kit (antibodies-online.com, Germany) The kit
is a sandwich enzyme immunoassay for in vitro quantitative
measurement of 8oxodG levels in DNA. NSC homogenateswere
treated according to the manufacturer's instruction. In brief,
cell lysates were added to the microtiter plate wells with a
biotin-conjugated polyclonal antibody preparation specific for
OGG1. Next, Avidin conjugated to Horseradish Peroxidase
(HRP) was added to each microplate well and incubated. After
TMB substrate solution was added, only those wells containing
OGG1, biotin-conjugated antibody and enzyme-conjugated
Avidin exhibited a change in color that was read at 450 nm.
The concentration of OGG1 in the samples is then determined
by comparing the O.D. of the samples to the standard curve.
RNA extraction, RT real-time PCR
Total RNA was extracted from cell cultures using OMNIZOL
(Euroclone, Italy), according to the manufacturer's protocol.
Levels of mRNA were measured by RT-PCR amplification, as
previously reported (Galderisi et al., 1999). Real-time PCR
assays were run on an Opticon-4 machine (Biorad, CA, USA).
The reactions were performed according to the manufacturer'sFigure 2 Panel A Top: The graphic shows the proliferation rate o
controlled release of FGF-2 (pHM/HS/FGF-2). The values represent t
times. Bottom: BrdU assay on NSCs grown in control medium and wi
standard deviation. Experiments were repeated three times. * pb
staining. The fluorescence photomicrograph is a representative pi
phosphatidylserine residues exposed on the outer layer of the cel
counterstained with Hoechst 33342 (blue). The table shows the mea
with controlled FGF-2 release (pHM/HS/FGF-2). * pb0.05. Bottom:
Panel C Quantitative senescence-associated beta-galactosidase ass
cultures with controlled FGF-2 release (pHM/HS/FGF-2). Data are
times. Statistically significant variations: *pb0.05. Panel D Polyacryl
NSCs grown in different conditions. The picture shows the PCR-ampl
internal control. The assay measures the enzymatic activity of telom
extracts adds a varying number of telomeric repeats (TTAGGG) onto
used to amplify the extended products. The M2 primer serves as a
products are then electrophoresed on a polyacrylamide gel. The int
reactions were properly carried out. Panel E Semi-quantitative RT-P
control and data are expressed in arbitrary units. Experiments w
*pb0.05.instructions using SYBRGreen PCR Master mix. The mRNA levels
were normalized with respect to HPRT, chosen as an internal
control. Each experiment was repeated at least three times.
The variations in gene expression are given as arbitrary units.
Western blotting
Cells were lysed in a buffer containing 0.1% Triton for
30 min at 4 °C. The lysates were then centrifuged for
10 min at 10,000 g at 4 °C. After centrifugation, 10–40 μg
of each sample was loaded, electrophoresed in a polyacryl-
amide gel, and electroblotted onto a nitrocellulose mem-
brane. All the primary antibodies were used according to
the manufacturers' instructions. Immunoreactive signals
were detected with a horseradish peroxidase-conjugated
secondary antibody (Santa Cruz, CA, USA) and reacted with
ECL plus reagent (GE Healthcare, Italy). Each reaction was
repeated at least three times. A semi-quantitative analysis
of protein levels was carried out by “Quantity One”
software associated with “Gel Doc 2000 System” (Biorad
Company, CA, USA).
Statistical analysis
Statistical significance was evaluated using ANOVA analysis,
followed by Student's t and Bonferroni's tests.
Results
The supplemental file 2 shows a schematic time-line of study
design.
Kinetics of FGF-2 release
Polyelectrolyte-modified HEMA hydrogel p[HEMA-co-METAC]
(pHM) were used to load FGF-2 both in presence and in
absence of heparan sulfate (HS) this to evaluate the effect off NSCs grown in classical medium (CTRL) and in a medium with
he mean±standard deviation. Experiments were repeated three
th controlled release of FGF-2. The values represent the mean±
0.05. Panel B Top: Detection of apoptotic cells by Annexin V
cture of NSCs stained with Annexin V (green), which binds to
l membrane during the early stages of apoptosis. Nuclei were
n expression values (±SD, n=3) in control (CTRL) and in cultures
Semi-quantitative RT-PCR analysis of BAX/BCL2 ratio. * pb0.05.
ay carried out on lysates obtained from control NSCs and from
expressed in arbitrary units. Experiments were repeated three
amide gel electrophoresis of TRAP assay products obtained from
ified products indicating telomerase activity. Black arrow: TRAP
erase. In the first step of the reaction, active telomerase in cell
the 3′ end of the substrate oligonucleotide M2 (TS). Next, PCR is
forward primer, while ACX is the reverse primer for PCR. The
ernal control of the reaction (arrow) demonstrates that the PCR
CR analysis of “stemness” genes. HPRT was used as the internal
ere repeated three times. Statistically significant variations:
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loaded hydrogels were incubated in 2 ml of PBS for 14 days at
37 °C in a humidified atmosphere. To mimic the NSC culture
conditions the PBS was changed every two days. Supernatants
were removed at different times and the amount of FGF-2 in
each sample was determined in triplicate by ELISA (Fig. 1). At
days 2, 4, 6, 8, 10, and 12 the amount of FGF-2 was
determined before medium change. The release of FGF-2
from p[HEMA-co-METAC] (pHM/FGF-2) in the absence of HS
was fast. Almost all the FGF-2 was released within 6 days. In
contrast, the release of FGF-2 after the addition of HS to
pHM was slower (Fig. 1). Concentration of FGF-2 in medium
containing pHM/FGF-2 was about 22 ng/ml at day 1; it
reached a peak of 30 ng/ml at day 2 and then declined
(Fig. 1). The level of FGF-2 in medium with pHM/HS/FGF-2
was about 7 ng/ml at day 1. It reached 18 ng/ml at day 6
and then remained stable for at least 6 more days (Fig. 1).
This result suggested that pHM/HS/FGF-2 polymer pro-
duced a better controlled-release of FGF-2. We then grew
NSCs in classical medium with FGF-2 supplementation every
two days (control cultures) or in a medium with pHM/HS/
FGF-2 polymer. In detail, pHM/HS/FGF-2 polymers were
pre-incubated for 5 days in PBS at 37 °C and then were
added to NSC cultures. Every 7 days, the polymer was
changed. We adopted this procedure to have a stable FGF-2
concentration in culture media.Effect of FGF-2 controlled release on cell
proliferation, apoptosis, and senescence
The cell proliferation curves showed a significant increase
(pb0.05) in cell growth of cultures incubated with pHM/HS/
FGF-2 compared with the control. Differences are particu-
larly evident at 14 and 28 days in vitro (Fig. 2A). This data is
in agreement with BrdU incorporation assay carried out at
the same time as points of cell proliferation analysis
(Fig 2A). In several experiments, we observed an increase
of S-phase cells in cultures treated with pHM/HS/FGF-2
compared with the control. Of note, at the beginning of
treatment (day 1 and day 3), we did not detect any significant
difference in proliferation rate between cells grown in pHM/
HS/FGF-2 and those grown in classical medium.
Annexin assays evidenced a reduced percentage of
apoptotic cells in cultures from pHM/HS/FGF-2 treated
samples as compared to the controls (Fig. 2B). Results are
in agreement with expression analysis of apoptosis-related
genes. In NSCs grown in pHM/HS/FGF-2, we detected a
decrease of Bax/Bcl-2 ratio compared to controls (Fig. 2B).
Also in this case, at the beginning of treatment (day 1 and
day 3), we did not detect any significant difference in
apoptosis rate in cells grown in pHM/HS/FGF-2 and those
grown in classical medium.
We observed progressive signs of senescence in cells grown
in classical medium, as detected by quantitative acid-beta-
galactosidase assay. Senescence increased also in pHM/HS/
FGF-2 treated cultures but it was lower than in the control
(Fig. 2C). To extend this finding, we measured telomerase
activity by a primer extension assay inwhich telomerase reverse
transcriptase (TERT) synthesizes telomeric repeats onto oligo-
nucleotide primers (TRAP assay). Extracts obtained from NSCs
grown in control medium were telomerase-positive, asexpected in stem cell samples. However, the telomerase
activity decreased during in vitro cultivation due to
progressive replicative senescence phenomena (Fig. 2D).
Of note, reduction in telomerase activity occurred more
slowly in NSC cultures with controlled delivery of FGF-2
(Fig. 2D).
Studies on transcriptional profiling of stem cells allowed a
preliminary identification of “stemness” genes participating
in the control of stem cell properties, such as self-renewal
ability and retention of an uncommitted state (Mikkers and
Frisen, 2005; Squillaro et al., 2010). We analyzed a panel of
embryonic stemness genes (Sox2, Nanog, Musashi-1 and
Tert) to evaluate the effects of FGF-2 controlled delivery on
their expression (Ferron et al., 2009; Leonard et al., 2009;
Sundberg et al., 2011). All the genes showed a progressive
decline of expression during in vitro cultivation (Fig. 2E).
Also in this case reduction in gene expression occurred more
slowly in NSC cultures with controlled delivery of FGF-2
compared with the control (Fig. 2E).
Altogether these results strongly suggest that controlled
delivery of FGF-2 decelerated the apoptosis and senes-
cence phenomena, which occur during in vitro cultivation
of NSCs.
Molecular analysis of controlled FGF-2 treatment
After analyzing the biological consequences of controlled
release of FGF-2 in NSCs, we attempted to elucidate the
molecular pathways involved. We analyzed the expression of
the P53-P21-P16-RB pathways, which are known to control
cell cycle arrest, differentiation, apoptosis, and/or senes-
cence processes (Campisi and d'Adda di Fagagna, 2007;
Galderisi et al., 2006).
In vitro cultivation of NSCs induced a significant upregulation
of P53 and P21 proteins (Fig. 3). This finding is in agreement
with progressive decrease of proliferative potential and onset of
senescence (Campisi and d'Adda di Fagagna, 2007; Galderisi
et al., 2006). Upregulation of these proteins was lower in pHM/
HS/FGF-2 treated cultures (Fig. 3).
In the control cultures, we detected a gradual down-
regulation of RB1 and an increase of RB2/P130 during in vitro
cultivation. This is in agreement with the role of RB2/P130 in
senescence and regulation of definitive cell cycle exit
(Helmbold et al., 2011). Accordingly, cultures with con-
trolled FGF-2 release showed lower expression of RB2/P130
since in these samples we detected higher proliferation and
less senescence compared with the control (Fig. 3).
Surprisingly, P16 protein levels did not change significantly
in NSC control cultures as expected in cells undergoing
replicative senescence. It should be pointed out that
senescence triggered by different stimuli might occur in a
P16-independent way (Haferkamp et al., 2009; Kim et al.,
2009; Zanichelli et al., 2012). Also in cultures with controlled
release of FGF-2 we did not detect a significant increase
during in vitro cultivation (Fig. 3).
FGF-2 release from loaded hydrogel prevents cell
fate skewing
Both control neurosphere cultures and those grown in dishes
with hydrogels were induced to differentiate by incubation
Figure 3 A representative gene expression analysis of RB- and P53-related pathways of NSCs grown in classical medium (CTRL) and
in a medium with controlled release of FGF-2 (pHM/HS/FGF-2). Protein levels were normalized with alpha-tubulin, chosen as the
loading control. The table shows protein mean expression values (±SD, n=3). Data are expressed in arbitrary units. For every
treatment (classical medium and controlled FGF-2 release, respectively) we carried out a statistical comparison of protein expression
at 7 days in vitro versus 14 and 28 days in vitro # pb0.05. Moreover, at each time point we carried out a statistical comparison
between CTRL and pHM/HS/FGF-2 samples. * pb0.05.
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FGF-2. Differentiation experiments were carried out on NSCs
that had been grown in proliferating media for 7, 14, and
28 days.
After three–five days of differentiation, we performed
immunofluorescent stainings to ascertain whether the prolif-
eration of NSCs in medium with controlled release of FGF-2
might modify cell fate specification. In addition, we detected
the expression levels of cell type-specific molecular markers
by semi-quantitative RT-PCR. We used primers specific for
MAP-2 and GFAP for neurons and astrocytes and primers
specific for CGT for oligodendrocytes (Jori et al., 2007).
Control NSCs cultivated for 7 days in proliferating
medium and then induced to differentiate displayed 50%of astrocytes, 22% of neurons and 6% of oligodendrocytes
(Fig. 4). This is in agreement with our previous results (Jori
et al., 2007). The percentage of differentiated cells from
NSCs grown in proliferating medium with controlled release
of FGF-2 did not change compared to control cultures,
suggesting that hydrogel do not alter differentiation
potential (Fig. 4).
It is well known that in vitro cultivation alters
differentiation potential of NSCs (Moses et al., 2006;
Ostenfeld et al., 2002; Pagani et al., 2006). Also in our
experimental system we detected a bias toward astrocyte
differentiation of NSCs as the days in vitro increased
(Fig. 4, compare 7 days versus 14 and 28 days). Neverthe-
less, the cultivation of NSCs in medium with controlled
92 U. Galderisi et al.release of FGF-2 slowed down the alteration of NSC
differentiation potential (Fig. 4). RT-PCR analysis of
differentiation markers confirmed the immunocytochem-
istry data (Fig. 4).Figure 4 Effects of controlled delivery of FGF-2 on the cell-fate of N
3 days onto poly-L-ornithine-coated plates in medium without FG
differentiated NSCs. Cells were stained for MAP-2 (green) and GFAP (r
Nuclei were counterstained with Hoechst 33342. The table shows the
oligodendrocytes obtained with different experimental conditions
expression levels of molecular markers of differentiation: MAP-2 (n
densitometric values, given as arbitrary units, were normalized with rOverall this finding is in agreement with results showing that
cultivation in presence of hydrogel-releasing FGF-2 improved
NSC proliferation and reduced senescence and apoptosis
phenomena.SCs grown in vitro for 7, 14, and 28 days and then differentiated for
F-2. Top: A representative fluorescence photomicrograph of
ed) (upper panel) or for Rip (green) and GFAP (red) (lower panel).
percentages of NSCs differentiated into neurons, astrocytes, and
(*pb0.05). Bottom: semiquantitative RT-PCR analysis of mRNA
eurons) and GFAP (astrocytes) and CGT (oligodendrocytes). The
espect to HPRT, chosen as internal control (*pb0.05).
Figure 5 Panel A Fluorimetric analysis of ROS production in NSC
cultures. The conversion of fluorogenic 2′,7′-dichlorodihydro-
fluorescein diacetate (DCFH-DA) to highly fluorescent dichloro-
fluorescein diacetate (DCF) within cells by ROSwasmeasuredwith
a fluorometric plate reader at 480 nm/530 nm. The histogram
shows the mean expression values (±SD, n=3) in control (CTRL)
and in cultures with controlled FGF-2 release (pHM/HS/FGF-2).
* pb0.05. Data are expressed as arbitrary units. Panel B Elisa
assay to detect 8oxodG level in NSC cultures. The histogram
shows the mean expression values (±SD, n=3) in control (CTRL)
and in cultures with controlled FGF-2 release (pHM/HS/FGF-2).
* pb0.05. Data are expressed as arbitrary units.
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oxidative stress
Oxidative stress occurs in all cell culture media. It is especially
important in media with low or no serum concentration
because many of the anti-oxidation properties of serum are
missing. Oxidative stress can modify both cells and cell
products. It can lead to cell apoptosis, and/or senescence.
Many formulation strategies aim to reduce oxidative stress
associated with serum-free and protein-free media. We
evaluated if controlled release of FGF-2 avoiding burst and
fall in hormone concentration may reduce cell stress. The
detection of ROS by Elisa assay evidenced that the production
of reactive oxygen species was significantly reduced in
cultures with controlled release of FGF-2 compared with
the control (Fig. 5A). Of note, this decrease in oxidative
stress produced less DNA damage, as detected with 8-oxodG
assay (Fig. 5B). This is in good agreement with reduced
apoptosis and senescence phenomena observed in NSCs
cultivated with hydrogel.Discussion
NSCs are stem cells in the nervous system that can self-renew
and give rise to differentiated progenitor cells to generate
lineages of neurons as well as glia, such as astrocytes and
oligodendrocytes. To facilitate the use of NSCs in clinical
scenarios, we need to explore the biology of these cells in
greater detail. One clear goal is to be able to definitively
identify, purify, and expand in vitro NSCs. Neural stem and
progenitor cells aremaintained and expanded as neurospheres
in chemically defined media, which are optimized for the
culture of human, mouse, and mammal neural stem cells
isolated from normal and tumor tissues. Exhaustion of growth
factors and an uncontrolled release with burst and fall in their
concentration may greatly affect the in vitro behavior of
NSCs. We evaluated the effect of a controlled release of FGF-2
in presence of HS on the expansion of NSCs in culture while
maintaining self-renewal, proliferation, and differentiation
potential.
Our results clearly evidenced that controlled release of
FGF-2 from polyelectrolyte hydrogel improved in vitro cultiva-
tion of NSCs. Cultures in presence of pHM/HS/FGF-2 showed a
higher proliferation rate, reduced apoptosis, and senescence
and preserve their stemness properties for a longer time
compared with the controls (Figs. 2, 3). Also of interest is that
cell fate properties are conserved as well (Fig. 4).
We demonstrated that controlled release of FGF-2
reduced the level of oxidative stress and this is associated
with a lower level of damaged DNA (Fig. 5). This result may
explain the reduced level of senescence and apoptosis in
NSCs cultivated in presence of hydrogel-releasing FGF-2.
Further studies could dissect the molecular mechanism that
associates controlled release of FGF-2 with reduction in ROS
production. It should be considered that this may be an
innovative research issue and few other reports have described
a connection between FGF-2 and oxidative stress. In detail some
findings provided evidences that FGF-2 can protect cultured
neurons fromROS accumulation (Mark et al., 1997; Zhang et al.,
1993). According to other scientists this antioxidant property of
FGF-2 may be related to its ability to induce the activity of
antioxidant enzymes (Mark et al., 1997; Zhang et al., 1993). It
remains to be determined why uncontrolled release of FGF-2 as
it occurs in classical NSC cultures produces more ROS than its
controlled release.
Collectively, our study supports the conclusion that
cultivation of NSCs in medium with controlled release of
FGF-2 optimizes proliferation and differentiation conditions
for NSCs. This result further proves the versatility of our
delivery platform, since in previous works we demonstrated
that pHM/HS/FGF-2 hydrogels promote maximal proliferation
and differentiation of other stem cells (Calarco et al., 2010;
De Rosa et al., 2004). Our delivery platform may contribute to
the development of a new class of biomaterial that enables
the prolonged controlled delivery of growth factors.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2012.09.001.
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